# Cites

> Cites is a VC fund in Sunchales backing Medical and Biotechnology. See 9 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Sunchales, Argentina
- Total investments: 9
- Last investment: Jan 2024
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/cites
- X (Twitter): https://www.twitter.com/cites_gss
- Website: http://www.cites-gss.com/
- Facebook: http://www.facebook.com/CitesGrupoSancorSeguros

Cites is a VC fund in Sunchales focused on Medical and Biotechnology. Cites Startups 2014 Center for Technological Innovation and Social Enterprise, a startup Sancor Insurance Group created to support innovation. They want to generate a cluster of technology companies and exercise role linker between research sectors, production, business and social. They do this by providing an interdisciplinary support betweentechnology and business, with the aim of strengthening the scientific, economic and social development of the region and country areas.

## Contacts

5 contacts available for Cites. Shizune tracks 3 team members at Cites. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cites-startups-2014?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 44% |
| Biotechnology | 4 | 44% |
| Medical Device | 4 | 44% |
| Health Care | 3 | 33% |
| Software | 2 | 22% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 8 | 89% |
| Series A | 1 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Argentina | 5 | 56% |
| United States | 4 | 44% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Nicolas Tognalli | Managing Partner | 1 | — |
| Ezequiel Manavela Chiapero | Chief Technology Business Developer | 0 | — |
| Gerardo R. Marchesini | Chief Scientific Business Developer and General Partner | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Teramot | Teramot’s AI software helps companies access data quickly and easily, improving decision-making with less effort. |  | Seed | Jan 01, 2024 |  |
| NeuroAcoustics | NeuroAcoustics helps treat neurological conditions by managing brain waves during sleep with personalized, simple devices. |  | Seed | Jan 01, 2024 |  |
| Selectivity Life | Selectivity Life is a healthcare company which develops reproductive medical devices which bring fertility treatments to patients' homes. | $180K | Seed | Jan 01, 2023 |  |
| Epiliquid | Epiliquid develops a platform for early cancer detection using specific biomarkers through liquid biopsies. |  | Seed | Jan 01, 2023 |  |
| Limay Biosciences | We use innovative biotechnologies to develop fast, simple and accessible molecular testing solutions. | $600K | Seed | Aug 12, 2022 |  |
| CRINSURANCE | CRINSURANCE offers a cryotank that preserves embryos safely and tracks them digitally, saving time for IVF labs. |  | Seed | Jan 01, 2021 |  |
| Stradot | Stradot creates high-speed, eco-friendly parking systems that save space and cut costs in crowded urban areas. |  | Seed | Jan 01, 2021 |  |
| Viewmind | ViewMind is a digital health and artificial intelligence company. It analyzes eye movement patterns using its AI-powered comprehensive neurocognitive health assessments. To detect and track Alzheimer's disease and other neurocognitive problems, ViewMind uses eye movement monitoring to acquire the most accurate type of brain health data. | $1M | Seed | Sep 01, 2020 |  |
| Eolo Pharma | Pharma develops molecular drugs intended to cure chronic inflammation. It specializes in the research and development of medicines that target the molecular and cellular basis of inflammation-related diseases. | $2.7M | Series A | Jan 07, 2020 |  |

9 of 9 investments shown.

## Co-investors
- [Agencia Córdoba Innovar y Emprender](https://shizune.co/investors/profile/agencia-c%C3%B3rdoba-innovar-y-emprender) — VC Fund, 1 deal together
- Ficus Capital — VC Fund, 1 deal together
- [SF500](https://shizune.co/investors/profile/sf500) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Cites invest in?

Cites invests primarily in Medical, Biotechnology and Medical Device startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in Argentina. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Cites?

Public channels for Cites include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Cites?

The team at Cites includes Nicolas Tognalli (Managing Partner), Ezequiel Manavela Chiapero (Chief Technology Business Developer) and Gerardo R. Marchesini (Chief Scientific Business Developer and General Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co